Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon W Lam

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Journal of Cardiac Failure|May 29, 2021
Captopril Versus Hydralazine-Isosorbide Dinitrate Vasodilator Protocols in Patients With Acute Decompensated Heart Failure Transitioning From Sodium NitroprussideMohamed Amar, Simon W Lam, Kathleen Faulkenberg, et al.
Critical Care Medicine|September 28, 2021
Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic ShockGretchen L Sacha, Simon W Lam, Lu Wang, et al.
Journal of Pharmacy Practice|January 25, 2014
Compliance With Institutional Antimicrobial Dosing Guidelines in Patients Receiving Continuous Venovenous HemodialysisMarianna Fedorenko, Simon W Lam, Lisa M Harinstein, et al.
International Journal of Clinical Pharmacy|October 30, 2020
Discharge prescription optimization by emergency medicine pharmacists in an academic emergency department in the United StatesJesse Castillo, Matthew J Campbell, Erick Sokn, et al.
The Annals of Pharmacotherapy|July 19, 2015
Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDSMahmoud A Ammar, Seth R Bauer, Stephanie N Bass, et al.
Pharmacotherapy|January 13, 2018
Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic ShockGretchen L Sacha, Simon W Lam, Abhijit Duggal, et al.
Journal of Critical Care|November 10, 2019
Cost-effectiveness of second-line vasopressors for the treatment of septic shockSimon W Lam, Erin F Barreto, Rachael Scott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Calming the "perfect storm" in methicillin-resistant Staphylococcus aureus bacteremia: a call for a more balanced discussionGregory A Eschenauer, Jerod L Nagel, Christine J Kubin, et al.
Journal of Intensive Care Medicine|November 30, 2020
Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic ShockSeth R Bauer, Gretchen L Sacha, Simon W Lam, et al.
The Western Journal of Emergency Medicine|January 31, 2020
Ketamine Safety and Use in the Emergency Department for Pain and Agitation/Delirium: A Health System ExperienceHanjie Mo, Matthew J Campbell, Baruch S Fertel, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Journal of Cardiac Failure|May 29, 2021
Captopril Versus Hydralazine-Isosorbide Dinitrate Vasodilator Protocols in Patients With Acute Decompensated Heart Failure Transitioning From Sodium NitroprussideMohamed Amar, Simon W Lam, Kathleen Faulkenberg, et al.
Critical Care Medicine|September 28, 2021
Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic ShockGretchen L Sacha, Simon W Lam, Lu Wang, et al.
Journal of Pharmacy Practice|January 25, 2014
Compliance With Institutional Antimicrobial Dosing Guidelines in Patients Receiving Continuous Venovenous HemodialysisMarianna Fedorenko, Simon W Lam, Lisa M Harinstein, et al.
International Journal of Clinical Pharmacy|October 30, 2020
Discharge prescription optimization by emergency medicine pharmacists in an academic emergency department in the United StatesJesse Castillo, Matthew J Campbell, Erick Sokn, et al.
The Annals of Pharmacotherapy|July 19, 2015
Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDSMahmoud A Ammar, Seth R Bauer, Stephanie N Bass, et al.
Pharmacotherapy|January 13, 2018
Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic ShockGretchen L Sacha, Simon W Lam, Abhijit Duggal, et al.
Journal of Critical Care|November 10, 2019
Cost-effectiveness of second-line vasopressors for the treatment of septic shockSimon W Lam, Erin F Barreto, Rachael Scott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Calming the "perfect storm" in methicillin-resistant Staphylococcus aureus bacteremia: a call for a more balanced discussionGregory A Eschenauer, Jerod L Nagel, Christine J Kubin, et al.
Journal of Intensive Care Medicine|November 30, 2020
Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic ShockSeth R Bauer, Gretchen L Sacha, Simon W Lam, et al.
The Western Journal of Emergency Medicine|January 31, 2020
Ketamine Safety and Use in the Emergency Department for Pain and Agitation/Delirium: A Health System ExperienceHanjie Mo, Matthew J Campbell, Baruch S Fertel, et al.
Pageof 8